C21 Investments Inc.

CXXI

CA12675Q1019

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 03:59:59 2024-04-26 pm EDT			5-day change	1st Jan Change
0.415 ^CAD	+5.06%		+1.22%	+29.69%

Mar. 15	C21 Investments Inc. announced that it expects to receive CAD 4 million in funding	CI
2023	C21 Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	CI

C21 Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022

December 15, 2022 at 07:27 am EST

C21 Investments Inc. reported earnings results for the third quarter and nine months ended October 31, 2022. For the third quarter, the company reported sales was USD 7.21 million compared to USD 7.94 million a year ago. Net income was USD 0.248507 million compared to USD 2.84 million a year ago.
For the nine months, sales was USD 21.86 million compared to USD 25.33 million a year ago. Net income was USD 2.41 million compared to USD 11.95 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to USD 0.1 a year ago. Diluted earnings per share from continuing operations was USD 0.02 compared to USD 0.1 a year ago. Basic earnings per share was USD 0.02 compared to USD 0.1 a year ago. Diluted earnings per share was USD 0.02 compared to USD 0.1 a year ago.

Latest news about C21 Investments Inc.

C21 Investments Inc. announced that it expects to receive CAD 4 million in funding	Mar. 14	CI
C21 Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	Dec. 14	CI
C21 Investments Swings to Loss in Fiscal Q2; Down 5.7%	23-09-21	MT
C21 Investments Swings to Loss in Fiscal Q2	23-09-21	MT
C21 Investments Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	23-09-21	CI
C21 Investments Inc. Announces Appointment of Aron Swan as Chief Operating Officer	23-09-07	CI
C21 Investments Swings to Loss in Fiscal Q1, Revenue Rises	23-06-29	MT
C21 Investments Inc. Reports Earnings Results for the First Quarter Ended April 30, 2023	23-06-29	CI
C21 Investments Inc. Reports Earnings Results for the Full Year Ended January 31, 2023	23-06-13	CI
C21 Investments' Fiscal Q4 Loss Widens, Revenue Falls; Completes Full Repayment of $30 Million Senior Secured Note	23-06-02	MT
C21 Investments' Shares Rally After Senior Secured Note Fully Repaid	23-06-02	DJ
C21 Investments' Fiscal Q4 Loss Widens, Revenue Falls; Completes Full Repayment of $30 Million Senior Secured Note	23-06-02	MT
C21 Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	22-12-15	CI
C21 Investments Q2 EPS US$0.02 Vs US$0.03 Year Ago; Revenue Falls	22-09-22	MT
C21 Investments Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	22-09-21	CI
C21 Investments Inc. Reports Earnings Results for the First Quarter Ended April 30, 2022	22-08-15	CI
An unknown buyer signed a binding agreement to acquire select assets in Oregon of C21 Investments Inc. for $2 million.	22-01-18	CI
C21 Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2021	21-12-16	CI
C21 Investments Inc. Reports Earnings Results for the Second Quarter Ended July 31, 2021	21-09-28	CI
C21 Investments Inc. Reports Earnings Results for the First Quarter Ended April 30, 2021	21-06-29	CI
C21 Investments Inc. Reports Earnings Results for the Full Year Ended January 31, 2021	21-05-31	CI
C21 Investments Inc. Auditor Raises 'Going Concern' Doubt	21-05-30	CI
C21 Investments Reports Sales Results for the First Quarter Ended April 30, 2021	21-05-17	CI
C21 Investments Inc. Expects to Yield of 2,500 Pounds of Additional High-Grade Flower Annually	21-05-17	CI
C21 Investments Inc. Announces Board Changes	21-01-29	CI

Chart C21 Investments Inc.

Duration

Period

More charts

Company Profile

C21 Investments Inc. is a Canada-based vertically integrated cannabis company. The Company cultivates, processes, and distributes cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry- retail revenues with multi-market branded consumer packaged goods. The Company holds licenses in Nevada spanning the entire cannabis supply chain. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of tetrahydrocannabinol (THC) and cannabidiol (CBD) products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. The Company operates in the state of Nevada.

Sector

Pharmaceuticals

Calendar

2024-07-15 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
C21 INVESTMENTS INC.	+29.69%	36.39M
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B